NCT04836403

Brief Summary

The purpose of our study was to validate the Chinese version of the Sinus and Nasal Quality of Life Survey (SN-5)and correlation with the incidence of pediatric obstructive sleep apnea and asthma. The study will enroll pediatric patients of rhino-sinusitis and their parents to finish Questionnaire 1, including Chinese version of SN-5, visual analogue scale (VAS), Pediatric allergy disease Pediatric Allergic Disease Quality of Life Questionnaire (PADQLQ), OSA-18 quality of Life Survey, and asthma-diagnostic questionnaire . Some patients re-tested SN-5 in 1 week later. After four weeks, participants finish these questionnaire 2, including SN-5, VAS, and PADQLQ. In addition, the author will invite health children without rhino-sinusitis disease and their parents to fill in Questionnaire 1. The Chinese version of SN-5 will be validated to establish its reliability and validity.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2016

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2017

Completed
3.2 years until next milestone

First Submitted

Initial submission to the registry

March 29, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 8, 2021

Completed
Last Updated

August 5, 2021

Status Verified

August 1, 2021

Enrollment Period

1.1 years

First QC Date

March 29, 2021

Last Update Submit

August 3, 2021

Conditions

Keywords

SN-5Quality of lifechildren

Outcome Measures

Primary Outcomes (3)

  • Test-retest reliability

    A nontreatment group was administered the SN-5 1 week later to assess test-retest reliability.

    1 week

  • Concurrent validity

    The correlation between SN-5 and VAS scores was used to analyze the concurrent validity of the SN-5.

    baseline

  • Discriminant validity

    Discriminant validity was assessed by calculating the difference between the SN-5 scores for participants with rhinosinusitis and for the healthy participants. These differences were analyzed with the Mann-Whitney U test.

    baseline

Secondary Outcomes (2)

  • the mean scores of SN-5

    4 week

  • correlation with score of SN-5 and score of OSA-18 quality of life questionnaire (OSA-18)

    baseline and 4 week

Study Arms (3)

Rhinosinusitis without treatment group

children aged 2 and 12 years with rhinosinusitis not receiving treatment

Other: Sinus and nasal quality of life survey questionnaire (SN-5)

Rhinosinusitis with treatment group

children aged 2 and 12 years with rhinosinusitis receiving treatment

Other: Sinus and nasal quality of life survey questionnaire (SN-5)

healthy volunteers

children aged 2 and 12 years without rhinosinusitis

Other: Sinus and nasal quality of life survey questionnaire (SN-5)

Interventions

The SN-5 consists of five questions on a 7-point scale that assesses the frequency of the following symptoms: (1) nasal obstruction, (2) sinus infection, (3) allergies, (4) emotional distress, and (5) activity limitations. The scoring system is as follows: 1 indicates "none of the time," 2 indicating "hardly any time at all," 3 indicates "a small part of the time," 4 indicates "some of the time," 5 indicates "a good part of the time," 6 indicates "most of the time," and 7 indicates "all of the time." Higher scores indicate more severe sinonasal symptoms. One item from a global faces scale scored from 0 to 10 is used to evaluate overall QoL related to nasal or sinus disease. Higher scores on this scale indicate a less severe impact of nasal or sinus disease. The scores from the first five items (1-7 each)

Rhinosinusitis with treatment groupRhinosinusitis without treatment grouphealthy volunteers

Eligibility Criteria

Age2 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Rhinosinusitis patients were recruited from pediatric clinics practicing Western or Chinese medicine

You may qualify if:

  • Children with one or more of the following symptoms, purulent nasal discharge, nasal congestion, cough, or postnasal drip for at least 1 month.

You may not qualify if:

  • craniofacial anomalies
  • cognitive deficits
  • illiteracy in traditional Chinese.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Lai WY, Kay DJ, Wei CC, Huang FW, Liang KL, Yen HR. Validation of the traditional Chinese version of the Sinus and Nasal Quality of Life Survey (SN-5) for children. Pediatr Neonatol. 2022 Jul;63(4):410-417. doi: 10.1016/j.pedneo.2022.01.008. Epub 2022 May 2.

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 29, 2021

First Posted

April 8, 2021

Study Start

December 1, 2016

Primary Completion

December 31, 2017

Study Completion

December 31, 2017

Last Updated

August 5, 2021

Record last verified: 2021-08